Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Late-Presenting People With HIV-1 Infection
BIC/FTC/TAF demonstrated robust virologic suppression and tolerability in patients presenting late in the course of HIV infection.
Authors
- Xiaoxin Xie
- Hai Long (ORCID: https://orcid.org/0000-0001-5744-5623)
- Lin Gan
- Yanhua Fu
- Shujing Ma
- Xiaoyan Yang (ORCID: https://orcid.org/0000-0003-3483-5658)
Institutions
- Shanghai Public Health Clinical Center (CN)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1093/ofid/ofae630
- Citations
- 5
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.95
Funders
- Science and Technology Program of Guizhou Province